Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)-Reference-Cited by-同舟云学术

Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Published:2017-09 Issue: Volume:135 Page:71-78
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Rahman Md. Motiur,Alatawi Yasser,Cheng Ning,Qian Jingjing,Plotkina Annya V.,Peissig Peggy L.,Berg Richard L.,Page David,Hansen Richard A.

Funder

U.S. Food and Drug Administration

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference50 articles.

1. Adverse drug event monitoring at the Food and Drug Administration;Ahmad;J. Gen. Intern. Med.,2003

2. Perspectives on the use of data mining in pharmaco-vigilance;Almenoff;Drug Saf.,2005

3. Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy, November 2006;American Academy of Neurology,2017

4. Approved drug products with therapeutic equivalence evaluations (Orange Book), 33rd ed. 2013. https://books.google.com/books?id=5uSMDAAAQBAJ&pg=PR10&lpg=PR10&dq=there+is+no+more+than+a+5%25+chance+that+a+generic+product+that+is+not+truly+equivalent+to+the+reference+will+be+approved&source=bl&ots=5W68qzSFqV&sig=KEUyQJ5eWbrqCh1xNZJCN18FsNY&hl=en&sa=X&ved=0ahUKEwjaro3zt4rQAhXCYSYKHej9DHsQ6AEIIDAB#v=onepage&q=there%20is%20no%20more%20than%20a%205%25%20chance%20that%20a%20generic%20product%20that%20is%20not%20truly%20equivalent%20to%20the%20reference%20will%20be%20approved&f=false. (Accessed 16 March 2017).

5. Suicide-related events in patients treated with antiepileptic drugs;Arana;N. Engl. J. Med.,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact and implications of national centralized drug procurement in China;International Journal of Clinical Pharmacy;2024-07-11

2. Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system;Frontiers in Pharmacology;2024-01-31

3. Attitudes towards the switching of anti-epileptic medications in pharmacies: the patients’ perspective;Postępy Psychiatrii i Neurologii;2023

4. The development of disposable electrochemical sensor based on MoSe2-rGO nanocomposite modified screen printed carbon electrode for amitriptyline determination in the presence of carbamazepine, application in biological and water samples;Chemosphere;2022-12

5. Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force;Epilepsia Open;2022-02-18